Thomas Steyer’s Farallon Capital is Buying These 10 Stocks
In this article, we discuss 10 stocks that Thomas Steyer’s Farallon Capital is buying.
Posts Tagged ‘NASDAQ:THRX’
Should You Buy Theravance Inc (THRX)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
What Happened To Billionaire Seth Klarman’s Top Biotech Picks In The Third Quarter?
Some investors think billionaire Seth Klarman is the next Warren Buffett. Given that Klarman's $31 billion fund, Baupost Group, has achieved average annual returns of 17% a...
Smart Money Don’t Bet on Three Biotech Stocks that Slumped Today and You Should Not Too
Smart money have been warning about the burst of the biotech bubble for a while now and it looks like they have been right on the money.
Billionaires Richard Perry and Seth Klarman Think Alike On American International Group Inc (AIG), Cheniere Energy Inc (LNG), Micron Technology Inc (MU), More
After compiling and analyzing the most recent 13F filings of hedge funds, we have found that Richard Perry’s Perry Capital and Seth Klarman’s Baupost Group keep around 14% ...
Billionaire Klarman’s Top Small-Cap Picks: ViaSat Inc., Theravance Inc., PBF Energy
The Baupost Group is a Boston-based hedge fund founded and operated by billionaire Seth Klarman.
Billionaire Seth Klarman’s Biotech Stock Picks
Billionaire Seth Klarman is a notorious investor who despite his uncoventional approaches always managed to achieve high returns.
Pitney Bowes Inc. (PBI) and Theravance Inc (THRX)’s Stakes Further Rise In Iridian’s Portfolio
In two recently amended filings David Cohen and Harold Levy's Iridian Asset Management has disclosed further increasing its passive stakes in Theravance Inc (NASDAQ:THRX) to...
Pitney Bowes Inc. (PBI), Graphic Packaging Holding Company (GPK), Theravance Inc (THRX): Iridian Asset Management’s Latest Moves
David Cohen and Harold Levy’s Iridian Asset Management filed several 13G forms with the U.S.
Seth Klarman’s Baupost Group Continues to Bet on Tech
On Wednesday, May 14th, Seth Klarman’s Baupost Group, presented its Form 13F Filing for the first quarter of 2014 at the U.S. Securities and Exchange Commission.
Baupost Group and Seth Klarman Are Fond of Micron Technology, Inc. (MU), Theravance Inc (THRX) & Others
Baupost Group, managed by Seth Klarman, in a new 13F filing, reported the holdings from its equity portfolio for the fourth quarter.
Relvar Ellipta: GlaxoSmithKline and Theravance’s Drug for Respiratory Diseases
Relvar Ellipta: Over the past few days, research-based pharmaceutical GlaxoSmithKline plc (ADR) (NYSE:GSK) and biopharmaceutical company Theravance Inc (NASDAQ:THRX)’s Relvar...
GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Could a Pair of Respiratory Disease Treatments Save This Big Pharma?
GlaxoSmithKline plc (ADR) (NYSE:GSK) and its partner Theravance Inc (NASDAQ:THRX) recently scored a second victory in their quest to treat chronic obstructive pulmonary disease...
Regeneron Pharmaceuticals Inc (REGN), Viropharma Inc (VPHM): Sanofi SA (ADR) (SNY)’s Interest Sparks Biotech Stocks in a Huge Week for Investors
Looking for the best-performing sector in this year's big market rally? It may just be the biotech sector, which has erupted with astronomical gains in 2013.
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Time to Bet on This Biotech Spinoff?
There hasn't been a dull moment for investors of Theravance Inc (NASDAQ:THRX) since the company submitted an NDA for COPD/asthma drug BREO before the Food and Drug Administration...
Theravance Inc (THRX): Are Hedge Funds Right About This Stock?
At the moment, there are many indicators investors can use to analyze stocks. Some of the most under-the-radar are hedge fund and insider trading activity.
GlaxoSmithKline plc (ADR) (GSK), Pfizer Inc. (PFE): Theravance Inc (THRX) Gets Big Win for New COPD Drug
Trading of biopharmaceutical company Theravance Inc (NASDAQ:THRX) was halted on Tuesday. A major decision hung in the balance as the U.S.
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Investors Should Brace for a Busy Week From the Biotech Sector
With second-quarter earnings season now in the books and about a month to go before third-quarter earnings kicks off, biotech savvy investors are in for a treat this week with...
Astex Pharmaceuticals, Inc. (ASTX), GlaxoSmithKline plc (ADR) (GSK), Cytokinetics, Inc. (CYTK): Last Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Incyte Corporation (INCY): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In the 21st century investor’s toolkit, there are many gauges shareholders can use to track their holdings.
This Metric Says You Are Smart to Sell Ariad Pharmaceuticals, Inc. (ARIA)
In the eyes of many investors, hedge funds are seen as overrated, old financial tools of a forgotten age.
Hedge Funds Aren’t Crazy About Charles River Laboratories (CRL) Anymore
In today’s marketplace, there are dozens of gauges shareholders can use to watch stocks. A pair of the most innovative are hedge fund and insider trading movement.
What Hedge Funds Think About Infinity Pharmaceuticals Inc. (INFI)
In the financial world, there are many methods shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading activity.
Should You Avoid Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ)?
In today’s marketplace, there are a multitude of gauges market participants can use to analyze their holdings.
Is Questcor Pharmaceuticals Inc (QCOR) Going to Burn These Hedge Funds?
In today’s marketplace, there are a multitude of methods shareholders can use to watch stocks.
What Hedge Funds Think About Medivation Inc (MDVN)
In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets.
Micron Technology, Inc. (MU), Theravance Inc (THRX): Here’s What Superinvestor Seth Klarman Has Been Buying
Today let's look at investing giant Seth Klarman, who founded the Baupost Group hedge fund company back in 1982. Klarman is a successful investor with a lot to teach us.
SandRidge Energy Inc. (SD), Freeport-McMoRan Copper & Gold Inc. (FCX): Litespeed’s Penchant For Distressed Assets Just Won’t Quit
Jamie Zimmerman founded Litespeed Management, an event-driven hedge fund focusing on special situations, distressed securities, and bankruptcies, in 2000.
Theravance Inc (THRX), Novartis AG (ADR) (NVS): Respiratory Drug Maker About to Take Off
Chronic obstructive pulmonary disease (COPD) is America’s third leading cause of death.
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Which of These COPD Treatments Will Come Out on Top?
To most people, cigarettes are often associated with lung cancer.
GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Pfizer Inc. (PFE): 3 Potential Game Changers for COPD
Over 13 million Americans have it. More than 120,000 of them die every year.
Is Elan Corporation, plc (ADR) (ELN) Pushing Its Luck?
Recently Elan Corporation, plc (ADR) (NYSE:ELN)'s shareholders voted against management's proposal to invest $1 billion in Theravance Inc (NASDAQ:THRX), a deal which a fellow...
Hedge Funds Are Betting On Theravance Inc (THRX)
In the eyes of most investors, hedge funds are seen as slow, old investment vehicles of yesteryear.
Hedge Funds Are Buying Incyte Corporation (INCY)
Is Incyte Corporation (NASDAQ:INCY) a buy, sell, or hold? Investors who are in the know are taking an optimistic view.
GlaxoSmithKline plc (ADR) (GSK), Sanofi SA (ADR) (SNY), Theravance Inc (THRX): This Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Merck & Co., Inc. (MRK), Illumina, Inc. (ILMN), GlaxoSmithKline plc (ADR) (GSK): The U.S.’s Deadliest Diseases
There's good news and bad news for Americans. The good news is that the age-adjusted death rate in the U.S.
Theravance Inc (THRX) Looks to Reward Shareholders by Splitting Into Two Distinct Companies
As part of the split, the pharmaceutical company looks poised to turn its current drug-marketing joint venture with London-based GlaxoSmithKline plc (ADR) (NYSE:GSK) into an...
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK), Elan Corporation, plc (ADR) (ELN): Who Benefits From This Market Moving Biotechnology Partnership?
Back towards the end of April 2013, Theravance Inc (NASDAQ:THRX) surprised everyone when it announced plans to split into two separate companies.
GlaxoSmithKline plc (ADR) (GSK), Eli Lilly & Co. (LLY): This Week in Biotech
With the SPDR S&P Biotech Index up 32% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
The City News: Antofagasta plc (ANTO), Rolls-Royce Holding PLC (RR), GlaxoSmithKline plc (GSK) & More
Editor's Note: Related tickers: Wal-Mart Stores, Inc. (NYSE:WMT), Tesco Corporation (USA) (NASDAQ:TESO), Goldman Sachs Group, Inc. (NYSE:GS), Virgin Media Inc.
Infinity Pharmaceuticals Inc. (INFI): Watch This Data
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was in 22 hedge funds' portfolio at the end of December. INFI has experienced an increase in enthusiasm from smart money of late.
NPS Pharmaceuticals, Inc. (NPSP), Vertex Pharmaceuticals Incorporated (VRTX): Double-Digit Returns from the Biotechnology Strategy
Investments in biotechnology by the average investor tend to deliver hit or miss returns over time.
Theravance Inc (THRX), Sterling Bancorp (STL): Shorts Are Piling Into These Stocks. Should You Be Worried?
The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long term.
GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX): Take a Deep Breath Before This Big FDA Decision
Every Sunday I make it a point to examine a combination of earnings stories or Food and Drug Administration panel reviews or PDUFA decisions in the upcoming week that you can'...
Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (SNY), Arena Pharmaceuticals, Inc. (ARNA) & Three Companies Ripe for a Takeover
One of the nice things about owning biotech companies is the large number of acquisitions in the sector.
Avanir Pharmaceuticals, Inc. (AVNR), Medivation Inc (MDVN) & This Week In Biotech
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Theravance Inc (THRX), Elan Corporation, plc (ADR) (ELN), GlaxoSmithKline plc (ADR) (GSK): Biotech Companies Breaking Up
Following in the footsteps of Abbott Laboratories (NYSE:ABT) spinning out its drug division into AbbVie Inc (NYSE:ABBV), and Pfizer spinning out its animal health division into...
Allergan, Inc. (AGN), Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK) & The Week, Biotech
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Price-Gainers News: Theravance Inc (THRX), Travelzoo Inc (TZOO), Arch Coal Inc (ACI)
Editor's Note: Related tickers: Theravance Inc (NASDAQ:THRX), GlaxoSmithKline plc (NYSE:GSK), Travelzoo Inc. (NASDAQ:TZOO), Arch Coal Inc (NYSE:ACI), Overstock.com, Inc.
Theravance Inc (THRX): Why Shares Rose Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
